Cargando…
Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021
Autores principales: | Britton, Amadea, Jacobs Slifka, Kara M., Edens, Chris, Nanduri, Srinivas Acharya, Bart, Stephen M., Shang, Nong, Harizaj, Adora, Armstrong, Jillian, Xu, Kerui, Ehrlich, Hanna Y., Soda, Elizabeth, Derado, Gordana, Verani, Jennifer R., Schrag, Stephanie J., Jernigan, John A., Leung, Vivian H., Parikh, Sunil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7976620/ https://www.ncbi.nlm.nih.gov/pubmed/33735160 http://dx.doi.org/10.15585/mmwr.mm7011e3 |
Ejemplares similares
-
Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021
por: Nanduri, Srinivas, et al.
Publicado: (2021) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021) -
Thrombocytopenia with Pfizer-BioNTech or Moderna COVID-19 vaccines
Publicado: (2021) -
Pfizer-BioNTech COVID-19 vaccine safe in children
Publicado: (2022) -
Tachycardia following Pfizer-BioNTech COVID-19 vaccine
por: Martins-Filho, Paulo Ricardo
Publicado: (2023)